[The relationship between the clinical effects of dibenzepin (Noveil) and its plasma concentration (author's transl)].
D000284:Administration, Oral; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004123:Dimethylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D000928:Antidepressive Agents; D001570:Benzodiazepinones; D004123:Dimethylamines
Uber die Abhängigkeit der klinischen Wirksamkeit des Dibenzepins (Noveril) von seiner Plasma-Konzentration